[What possibilities exist to modify cataract development on the basis of current biochemical knowledge? Where can

Klinische Monatsblatter Fur Augenheilkunde
|June 1, 1985
PubMed

Insights

Senile cataract formation is multifactorial, not solely due to aging. Research highlights the potential of aldose reductase inhibitors and antioxidants to prevent lens opacities in experimental models.

Area of Science:

  • Ophthalmology and Biochemistry
  • Lens biology and age-related changes

Context:

  • Senile cataract development is increasingly understood as multifactorial, involving both internal and external risk factors beyond simple aging.
  • Epidemiological studies have identified specific risk factors contributing to cataractogenesis.
  • Experimental models, including those induced by excess carbohydrates, naphthalene, and ionizing radiation, are crucial for understanding damaging mechanisms.

Purpose:

  • To investigate the multifactorial origins of senile cataract and evaluate potential countermeasures.
  • To elucidate the mechanisms of cataract formation using various experimental models.
  • To assess the efficacy of therapeutic interventions, such as aldose reductase inhibitors and antioxidants.

Summary:

  • Age-related lens changes are insufficient to explain senile cataract; a multifactorial etiology involving endogenous and exogenous factors is indicated.
  • Experimental models demonstrate that diabetic cataracts (induced by Streptozotocin) can be completely prevented by aldose reductase inhibitors, even with co-exposure to other cataractogens like naphthalene and X-rays.
  • Naphthalene-induced damage involves increased oxidative stress on lens proteins, suggesting that enhancing the lens's antioxidative capacity is a viable countermeasure.

Impact:

  • Findings from animal experiments provide a foundation for developing more effective anticataract drugs.
  • Identifies specific pathways (e.g., oxidative stress, aldose reductase activity) involved in cataract formation.
  • Suggests a paradigm shift from solely age-related causes to a broader understanding of cataract etiology and prevention strategies.

Related Concept Videos

Drug Biotransformation: Overview01:16

Drug Biotransformation: Overview

Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
Principles of Drug Action01:24

Principles of Drug Action

Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Prodrugs01:30

Prodrugs

Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...